Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
Lionel Adès(Délégation Paris 7), Pierre Fenaux(Saint Louis University Hospital), Pau Montesinos(Instituto de Salud Carlos III), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse), Consuelo Rayón(European Union), Sandrine Meyer‐Monard(University Hospital of Basel), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Stéphane de Botton(Université Paris-Saclay), Patrice Chevallier(Hotel Dieu Hospital), Norbert Ifrah(Institut National du Cancer), Augustin Ferrant(Cliniques Universitaires Saint-Luc), Thomas Pabst(University Hospital of Bern), Anne Vekhoff(Hôtel-Dieu de Paris), Thierry Lamy(Centre Hospitalier Universitaire de Lille), Jean‐Yves Cahn, Edo Vellenga(University Medical Center Groningen), Sylvie Chevret(Saint Louis University Hospital), Ricardo Parody(Hospital Universitario Virgen del Rocío), Silvia Negri(Hospital Doctor José Molina Orosa), Emmanuel Raffoux(Inserm), Juan Bergua(Hospital San Pedro de Alcántara), Xavier Thomas(Hôpital Lyon Sud), Javier de la Serna(Hospital Universitario 12 De Octubre), Dominique Bron, Laurent Degos(Inserm), Anne Marie Stoppa, Hervé Dombret(University of London Institute in Paris), Agnès Guerci(Centre Hospitalier Régional et Universitaire de Nancy), Arnaud Pigneux(Centre Hospitalier Universitaire de Bordeaux)
Cited by 157
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k